drugset / Trial / NCT04448223
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of CKD-351
Timeline
- Start
- 2020-06-11
- Primary completion
- 2022-12-05
- Completion
- 2022-12-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dorzolamide | Small molecule | 20 mg/ml | — |
| Subject | Latanoprost | Small molecule | 25 ug/ml | — |
| Subject | Latanoprost | Small molecule | 50 ug/ml | — |